Filing Details
Krystal Biotech, Inc. (NASDAQ:KRYS) filed a Form 8-K with the Securities and Exchange Commission on July 21, 2026, disclosing a material event.
8k filedNASDAQ:KRYS
Krystal Biotech, Inc. (KRYS) Reports Material Event to SEC
Filing Details Krystal Biotech, Inc. (NASDAQ:KRYS) filed a Form 8-K with the Securities and Exchange Commission on July 21, 2026, disclosing a material event. Market Context…
Market Context
Krystal Biotech, Inc.'s stock currently trades at $339.06 with a market capitalization of $7.2B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Krystal Biotech, Inc.'s stock.
All SEC filings for Krystal Biotech, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View KRYS Stock Page
Frequently Asked Questions
Where can I read KRYS's SEC filings?
Browse all filings on our KRYS SEC filings page.
What types of SEC filings does Krystal Biotech, Inc. file?
Public companies like Krystal Biotech, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.